Article Type
Changed
Mon, 05/03/2021 - 12:17

Key clinical point: There could be a possible relationship between organizing pneumonia (OP) and karyotype der(1;7)(q10; p10) in myelodysplastic syndrome (MDS).

Major finding: Overall, 5 (3.1%) patients developed pathologically diagnosed OP, of which 3 had der(1;7)(q10; p10) abnormality. The chances of developing OP was higher among patients with vs. without der(1;7)(q10;p10) abnormality (odds ratio, 25.70; 95% confidence interval, 2.582-347.400).

Study details: Findings are from a retrospective analysis of 159 patients with high-risk MDS.

Disclosures: No funding source was identified. The authors declared no potential conflicts of interest.

Source: Matsunawa M et al. Br J Haematol. 2021 Apr 14. doi: 10.1111/bjh.17473.

 

 

Publications
Topics
Sections

Key clinical point: There could be a possible relationship between organizing pneumonia (OP) and karyotype der(1;7)(q10; p10) in myelodysplastic syndrome (MDS).

Major finding: Overall, 5 (3.1%) patients developed pathologically diagnosed OP, of which 3 had der(1;7)(q10; p10) abnormality. The chances of developing OP was higher among patients with vs. without der(1;7)(q10;p10) abnormality (odds ratio, 25.70; 95% confidence interval, 2.582-347.400).

Study details: Findings are from a retrospective analysis of 159 patients with high-risk MDS.

Disclosures: No funding source was identified. The authors declared no potential conflicts of interest.

Source: Matsunawa M et al. Br J Haematol. 2021 Apr 14. doi: 10.1111/bjh.17473.

 

 

Key clinical point: There could be a possible relationship between organizing pneumonia (OP) and karyotype der(1;7)(q10; p10) in myelodysplastic syndrome (MDS).

Major finding: Overall, 5 (3.1%) patients developed pathologically diagnosed OP, of which 3 had der(1;7)(q10; p10) abnormality. The chances of developing OP was higher among patients with vs. without der(1;7)(q10;p10) abnormality (odds ratio, 25.70; 95% confidence interval, 2.582-347.400).

Study details: Findings are from a retrospective analysis of 159 patients with high-risk MDS.

Disclosures: No funding source was identified. The authors declared no potential conflicts of interest.

Source: Matsunawa M et al. Br J Haematol. 2021 Apr 14. doi: 10.1111/bjh.17473.

 

 

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: MDS May 2021
Gate On Date
Fri, 04/02/2021 - 10:00
Un-Gate On Date
Fri, 04/02/2021 - 10:00
Use ProPublica
CFC Schedule Remove Status
Fri, 04/02/2021 - 10:00
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads